NeuroPace (NPCE) Cash & Equivalents (2020 - 2026)
NeuroPace's Cash & Equivalents came in at $12.54 million for Q2 2026, down 45.1% from $22.86 million a year earlier and down 15.2% from the prior quarter.
Powered by 
Analysis
NeuroPace (NPCE) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, NeuroPace's Cash & Equivalents was $21.69 million, up 61.5% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -3.8% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $13.43 million in FY2024 (-25.6%), $18.06 million in FY2023 (+173.4%), $6.61 million in FY2022 (-65.6%) and $19.19 million in FY2021 (-27.3%).
- The Q2 2026 figure represents the lowest quarterly Cash & Equivalents since Q3 2023.
- Year-over-year, Cash & Equivalents increased in five of the last eight quarters, with growth averaging 28.0%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2023 (growth of 173.4%), and the weakest in Q2 2022 (a decline of 81.8%).
- Business Quant data shows NPCE's Cash & Equivalents at $14.78 million (Q1 2026), $21.69 million (Q4 2025) and $20.65 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 4.06 Bn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 5.10 Bn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 4.35 Bn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 2.76 Bn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 3.39 Bn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 539.00 Mn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 2.91 Bn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 708.00 Mn |
| 10 | NeuroPace | 471.73 Mn | 244.98 Mn | 18.91 Mn | 12.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.54 Mn |
| Mar 31, 2026 | 14.78 Mn |
| Dec 31, 2025 | 21.69 Mn |
| Sep 30, 2025 | 20.65 Mn |
| Jun 30, 2025 | 22.86 Mn |
| Mar 31, 2025 | 27.02 Mn |
| Dec 31, 2024 | 13.43 Mn |
| Sep 30, 2024 | 15.42 Mn |
| Jun 30, 2024 | 12.84 Mn |
| Mar 31, 2024 | 13.00 Mn |
| Dec 31, 2023 | 18.06 Mn |
| Sep 30, 2023 | 9.72 Mn |
| Jun 30, 2023 | 7.86 Mn |
| Mar 31, 2023 | 6.72 Mn |
| Dec 31, 2022 | 6.61 Mn |
| Sep 30, 2022 | 5.69 Mn |
| Jun 30, 2022 | 5.70 Mn |
| Mar 31, 2022 | 7.49 Mn |
| Dec 31, 2021 | 19.19 Mn |
| Sep 30, 2021 | 26.63 Mn |
API Access
NeuroPace Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NPCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NPCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NPCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();